Globus Medical Inc
GMED· NYSE
GMEDGlobus Medical Inc
Released Nov 4, 2021, after the close
10-Q filed Nov 4, 2021, 35 days after period end · 0001562762-21-000415
| Metric | Q3 2021 | Q3 2020 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $229.72M | $216.10M | $151.74M | $135.65M |
| Net Income | $47.21M | $44.22M | $25.59M | $26.23M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.45 |
| $0.44 |
| $0.26 |
| $0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
